You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Made in India Sputnik V to be available during Sept-October: Dr Reddy's

RDIF has tied up with six Indian drug makers to manufacture Sputnik V.

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  Hyderabad 

Sputnik

Dr Reddy's Laboratories Ltd expects the locally manufactured Russia's COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said on Tuesday.

M V Ramana, CEO of Branded Markets (India and Emerging Markets), Dr Reddys, said due to the sudden spike of COVID-19 cases in Russia, the arrival of Sputnik V doses are getting delayed and the situation may ease by August end.

"The local manufacturers are currently in the process of Technology absorption and scale up.

And we expect and from the October-September timeframe we are likely to have locally manufactured sputnik available," Ramana told reporters.

Dr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft launched the vaccine in India in May 2021 after receiving Emergency Use Authorization (EUA) in April 2021.

Ramana said the company is in discussions with RDIF for ramping up supplies.

RDIF has tied up with six Indian drug makers to manufacture Sputnik V.

Dr Reddy's is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of COVID-19 vaccineSputnikVin India.

The official said the vaccine was launched in 80 cities and over 2.5 lakh people have been administered the jab.

Replying to a query, he said the trials of Sputnik V in adolescents have commenced in Russia and they are expected to be completed by October.

On the arrival of more Sputnik V stock from RDIF, Ramana said "What we wait for now is the balance of the second dose and we are in discussions with RDIF.

We do expect to hear back from them by the end of July.

The indications are that in the month of August we should start seeing a bit of floor of the imported product."

Meanwhile, Dr Reddy's, in a press release, said SVAAS Wellness Limited, a wholly-owned subsidiary of the drug maker, tied up with ICICI Lombard General Insurance Company Limited for a pilot launch of a first-of-its-kind cashless outpatient offering in India.

The partnership marks the launch of Dr.Reddys digital health solution 'SVAAS' and demonstrates ICICI Lombards deeper foray into the wellness space.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, July 27 2021. 18:11 IST
RECOMMENDED FOR YOU